Your browser doesn't support javascript.
loading
Pharmacokinetics and safety of first-line tuberculosis drugs rifampin, isoniazid, ethambutol, and pyrazinamide during pregnancy and postpartum: results from IMPAACT P1026s.
Van Schalkwyk, Marije; Bekker, Adrie; Decloedt, Eric; Wang, Jiajia; Theron, Gerhard B; Cotton, Mark F; Eke, Ahizechukwu C; Cressey, Tim R; Shapiro, David E; Bacon, Kira; Knowles, Kevin; George, Kathleen; Browning, Renee; Chakhtoura, Nahida; Rungruengthanakit, Kittipong; Wiesner, Lubbe; Capparelli, Edmund V; Stek, Alice M; Mirochnick, Mark; Best, Brookie M.
Afiliação
  • Van Schalkwyk M; Division of Adult Infectious Diseases, Department of Medicine, Family Centre for Research with Ubuntu, Stellenbosch University and Tygerberg Hospital , Cape Town, South Africa.
  • Bekker A; Department of Pediatrics and Child Health, Family Centre for Research with Ubuntu, Stellenbosch University and Tygerberg Hospital , Cape Town, South Africa.
  • Decloedt E; Division of Clinical Pharmacology, Department of Medicine, Stellenbosch University and Tygerberg Hospital , Cape Town, South Africa.
  • Wang J; Department of Biostatistics, Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health , Boston, Massachusetts, USA.
  • Theron GB; Department of Obstetrics and Gynecology, Stellenbosch University , Cape Town, South Africa.
  • Cotton MF; Department of Pediatrics and Child Health, Family Centre for Research with Ubuntu, Stellenbosch University and Tygerberg Hospital , Cape Town, South Africa.
  • Eke AC; Division of Maternal Fetal Medicine and Clinical Pharmacology, Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine , Baltimore, Maryland, USA.
  • Cressey TR; AMS-PHPT Research Collaboration, Faculty of Associated Medical Sciences, Chiang Mai University , Chiang Mai, Thailand.
  • Shapiro DE; Department of Biostatistics, Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health , Boston, Massachusetts, USA.
  • Bacon K; Frontier Science Foundation , Amherst, New York, USA.
  • Knowles K; Frontier Science Foundation , Amherst, New York, USA.
  • George K; FHI 360 , Durham, North Carolina, USA.
  • Browning R; Division of AIDS, National Institute of Allergy and Infectious Diseases, NIH , Bethesda, Maryland, USA.
  • Chakhtoura N; Maternal and Pediatric Infectious Disease Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) , Bethesda, Maryland, USA.
  • Rungruengthanakit K; Research Institute for Health Sciences, Chiang Mai University , Chiang Mai, Thailand.
  • Wiesner L; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town , Cape Town, South Africa.
  • Capparelli EV; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California , San Diego, California, USA.
  • Stek AM; Department of Pediatrics, School of Medicine, University of California , San Diego, California, USA.
  • Mirochnick M; Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of Southern California School of Medicine , Los Angeles, California, USA.
  • Best BM; Division of Neonatology, Department of Pediatrics, Boston University Chobanian & Avedisian School of Medicine , Boston, Massachusetts, USA.
Antimicrob Agents Chemother ; 67(11): e0073723, 2023 11 15.
Article em En | MEDLINE | ID: mdl-37882552

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Tuberculose / Antituberculosos Limite: Adolescent / Female / Humans / Pregnancy Idioma: En Revista: Antimicrob Agents Chemother Ano de publicação: 2023 Tipo de documento: Article País de afiliação: África do Sul

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Tuberculose / Antituberculosos Limite: Adolescent / Female / Humans / Pregnancy Idioma: En Revista: Antimicrob Agents Chemother Ano de publicação: 2023 Tipo de documento: Article País de afiliação: África do Sul